COMMUNIQUÉS West-GlobeNewswire

Emblem Corp. Signs Letter of Intent to Acquire Natura Naturals
26/07/2018
Acquisition adds up to 70,000kg/yr capacity to support aggressive growth plan TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (OTCBB:EMMBF) (“Emblem” or the “Company”), announced today that it has [...]
Pain Therapeutics Reports Second Quarter 2018 Financial Results
26/07/2018
AUSTIN, Texas, July 26, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a drug development company, today reported financial results for the second quarter ended June 30, 2018. Net loss was $2.5 million [...]
Asterias Biotherapeutics to Report Second Quarter 2018 Results on August 9, 2018
26/07/2018
FREMONT, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Athenex Announces That Two Phase 3 Pivotal Efficacy Studies of KX2-391 in Actinic Keratosis Achieved Their Primary Endpoints
26/07/2018
BUFFALO, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Aclaris Therapeutics to Announce Second Quarter 2018 Financial Results on August 3, 2018
26/07/2018
WAYNE, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018
26/07/2018
- Initiation of Phase 1, first-in-human clinical trial of MCLA-158 in patients with solid tumors - - MCLA-128’s unique mechanism of action published in the scientific journal Cancer Cell - UTRECHT, The Netherlands, July [...]
Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year
26/07/2018
Completed Enrollment for the FDA STEMI DTU Safety and Feasibility Study DANVERS, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support [...]
VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update
26/07/2018
-- Pivotal Phase 3 program for Sci-B-Vac ® Hepatitis B vaccine continues to advance towards topline data expected mid-year 2019 -- -- Positive safety and immunogenicity data from Phase 1 study of VBI-1501 for Congenital [...]
Essilor - News Release: Proposed combination between Essilor and Luxottica approved in China
26/07/2018
Proposed combination between Essilor and Luxottica approved in China PDF version of the news release Charenton-le-Pont, France and Milan, Italy (July 26, 2018 ) - Essilor (Euronext Paris: EI) and Luxottica (MTA: LUX) [...]
Essilor - Communiqué : La Chine autorise le projet de rapprochement entre Essilor et Luxottica
26/07/2018
La Chine autorise le projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 26 juillet 2018 ) - Essilor (Euronext Paris : EI) et Luxottica (MTA : LUX [...]
RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST HALF 2018. REVENUES +6.9%, OPERATING INCOME +14.1%, NET INCOME +11.7%
26/07/2018
RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST HALF 2018. REVENUES +6.9%, OPERATING INCOME +14.1%, NET INCOME +11.7%. Consolidated revenues € 696.1 million, +6.9%. EBITDA (1) € 260.0 million, +16.1% Operating [...]
PotNetwork Holdings, Inc. Engages New PCAOB Member Audit Firm For Form 10 Registration Statement Refiling
26/07/2018
FT LAUDERDALE, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company has engaged a new PCAOB-member firm, Manohar, Chowdhry & Associates [...]
Opthea Meets Primary Safety Objective with OPT-302 in Phase 1b Diabetic Macular Edema Clinical Trial
26/07/2018
MELBOURNE, Australia, July 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing novel biologic therapies to treat back-of-the eye diseases, announced today that its [...]
Carlyle Dental Announces New iTero® Digital Scanning System
26/07/2018
KINSTON, N.C., July 26, 2018 (GLOBE NEWSWIRE) -- Carlyle Dental, located in Kinston, North Carolina and serving the communities of Goldsboro, Greenville is excited to announce the addition of the iTero® Scanner to their [...]
RadioMedix and ITM announce agreement for manufacturing of Ge-68/Ga-68 generators in U.S.
26/07/2018
Houston (TX, USA) and Garching (Germany), July 26, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. and ITM Isotopen Technologien München (ITM), a specialized radiopharmaceutical group of companies announced today that ITM’s [...]
Ossur Hf : Interim report Q2 2018
26/07/2018
Announcement no. 47/2018 Interim report Q2 2018 26 July 2018 Highlights Sales amounted to USD 158 million, corresponding to 9% USD growth and 6% organic growth. Sales for 1H 2018 amounted to USD 300 million, [...]
Financière de Tubize SA: Half-year Financial Report 2018
26/07/2018
Press release 26 July 2018 Embargo till 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, day-to-day management, aspijcke@icloud.com 2018 half-year financial report [...]
Financière de Tubize SA: Rapport financier semestriel 2018
26/07/2018
Communiqué de presse 26 juillet 2018 Embargo jusqu'à 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, directeur, aspijcke@icloud.com Rapport financier semestriel [...]
Shire plc : Rule 2.9 Announcement
26/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 26 July 2018 Shire [...]

Pages